Gapp, Bianca V
Konopka, Tomasz https://orcid.org/0000-0003-3042-4712
Penz, Thomas
Dalal, Vineet
Bürckstümmer, Tilmann
Bock, Christoph
Nijman, Sebastian MB https://orcid.org/0000-0003-0464-6661
Funding for this research was provided by:
European Research Council (311166)
Boehringer Ingelheim Fonds
Article History
Received: 16 February 2016
Revised: 6 July 2016
Accepted: 7 July 2016
First Online: 1 August 2016
Conflict of interest
: SMBN is a co‐founder and shareholder of Haplogen GmbH. The company employs haploid genetics in the area of infectious disease. TB is an employee of Horizon Genomics GmbH. The company generated the human tyrosine kinase knockout collection based on HAP1 cells.